First Page | Document Content | |
---|---|---|
Date: 2013-01-08 12:20:51Science Pharmaceutical sciences Design of experiments Pharmacology Food and Drug Administration Clinical trial Informed consent Internet privacy Adverse event Clinical research Pharmaceutical industry Research | RASCAL Study Description Help TextAdd to Reading ListSource URL: www.cumc.columbia.eduDownload Document from Source WebsiteFile Size: 20,39 KBShare Document on Facebook |
Print Form Alabama Board of Medical Examiners P.O. Box 946, Montgomery, ALOffice-Based Surgery Adverse Event Report FormDocID: 1vm7X - View Document | |
Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines forDocID: 1vily - View Document | |
National Action Plan for Adverse Drug Event PreventionDocID: 1v1KN - View Document | |
Microsoft Word - FINAL-Formatted-University Adverse Weather and Emergency Event Policy -effDocID: 1uZd2 - View Document | |
National Action Plan for Adverse Drug Event PreventionDocID: 1uxaR - View Document |